UBX1325 - CAS 2271269-01-1

UBX1325, a Bcl-xL inhibitor, enhances apoptosis in senescent cells, serving as an effective anti-aging agent. It holds potential for age-related eye disease research, including diabetic macular oedema (DME), age-related macular degeneration (AMD), and diabetic retinopathy (DR) [1].

Others, Apoptosis, Bcl-2 Family

Apoptosis, Others

2271269-01-1

C53H59ClF3N6O10PS3

1159.69

C(O)(=O)C=1C(=C(N(C(C)C)C1C)C2=CC=C(Cl)C=C2)C3=CC(=CC=C3)N4CCN(CC4)C5=CC=C(NS(=O)(=O)C6=CC(S(C(F)(F)F)(=O)=O)=C(N[C@H](CCN7CCC(OP(=O)(O)O)CC7)CSC8=CC=CC=C8)C=C6)C=C5

-20°C

Ice Packs

Small Compound